Skip to main content

Table 2 Patient Demographics

From: Real-life use of onabotulinumtoxinA for symptom relief in patients with chronic migraine: REPOSE study methodology and baseline data

Characteristic

6-Month Completers

(n = 336) a

Age (years)

 

 Mean (SD)

44.9 (11.4)

 Median (min, max)

46.0 (18, 76)

Age group (years), n (%)

 

  ≥ 18 and <30

33 (9.8)

  ≥ 30 and <40

80 (23.8)

  ≥ 40 and <50

107 (31.8)

  ≥ 50

115 (34.2)

Gender, n (%)

 

 Male

49 (14.6)

 Female

287 (85.4)

Weight (kg)

 

 Mean (SD)

68.6 (14.3)

 Median (min, max)

65 (46, 150)

Height (cm)

 

 Mean (SD)

167.4 (8.3)

 Median (min, max)

167 (150, 203)

Body mass index (kg/m2)

 

 Mean (SD)

24.5 (4.5)

 Median (min, max)

24 (16, 43)

Education, n (%)b

 

 No school-leaving qualifications

6 (1.8)

 Still attending school

0

 Secondary school certificate (‘Hauptschule’)

69 (20.5)

 Secondary school certificate (‘Realschule’)

116 (34.5)

 Higher education entrance qualification

71 (21.1)

 University degree

59 (17.6)

Employment Status, n (%)c

 

 Full time

179 (53.3)

 Part time

43 (12.8)

 Retiree

20 (6.0)

 Unemployed

20 (6.0)

 Pupil

1 (0.3)

 Trainee

3 (0.9)

 Student

6 (1.8)

 Self-employed

10 (3.0)

 Housewife/husband

26 (7.7)

 Side job

4 (1.2)

 Pensioner

15 (4.5)

  1. aOnly gender data was available for 1 patient
  2. bEducation data were unavailable for 15 patients
  3. cEmployment data were unavailable for 9 patients